Download Trophon included in new AIUM guidelines

19 May 2014
Company Announcements Office
Australian Securities Exchange
Trophon® EPR included in new guidelines from the American Institute of Ultrasound in
Medicine (AIUM)
The American Institute of Ultrasound in Medicine (AIUM) has updated its Guidelines for
Cleaning and Preparing External and Internal Use Ultrasound Probes Between Patients .
reinforcing stricter controls for high level disinfection of ultrasound probes.
The recently updated guidelines include trophon in its recommendations for high level
disinfection.
“Having trophon EPR mentioned in the AIUM guidelines, which are recognised and respected
internationally, is excellent news for Nanosonics,” said Michael Kavanagh, President/CEO,
Nanosonics. “This is a further step towards achieving our goal of establishing trophon globally
as the new standard of care for ultrasound probe disinfection.”
The reference to trophon in the guidelines follows inclusion of a recommendation from the
Centers for Disease Control (CDC) for environmental infection control in the case of Clostridium
difficile.
C. difficile bacteria cause infectious, antibiotic-resistant enteritis (abdominal pain, diarrhoea and
fever), which can cause serious problems for healthcare facilities. The trophon EPR has proven
disinfection efficacy against C. difficile spores, which are highly resistant to disinfection.
AIUM recommends operators ensure their facilities are able to minimise exposure to potentially
dangerous liquid disinfectants. As a fully enclosed system, the trophon EPR ensures operators
and patients are not exposed to toxic chemicals. There are no hazardous waste to dispose of
afterwards as the only by-products are oxygen and water.
The guidelines also advise operators check with probe manufacturers as to whether their probe
handles can be immersed in liquid disinfectants. With a number of important studies showing
significant levels of handle contamination (up to 80%) following immersion disinfection
processes, this issue is being increasingly recognised. The trophon EPR disinfects both the
probe head and handle and is approved for use with over 500 probes.
“The trophon EPR offers customers a solution to ensure they meet the new guidelines,” said Mr
Kavanagh. “The reference is highly positive for Nanosonics’ market positioning of trophon EPR.
We expect to see further movements with regulations and guidelines, and a trend towards
stricter controls for high level disinfection.”
Nanosonics Limited ABN 11 095 076 896 Unit 24 566 Gardeners Road, Alexandria NSW 2015 Australia
Tel: +61 2 8063 1600 Fax: +61 2 8063 1600 Email: inf [email protected] w: www.nanosonics.com.au
Established more than 50 years ago, the AIUM is a multidisciplinary medical association of
more than 9000 physicians, sonographers, scientists, students, and other health care providers
dedicated to advancing the safe and effective use of ultrasound in medicine.
Michael Kavanagh
President / Chief Executive Officer
For more information please contact:
Michael Kavanagh, President/CEO or McGregor Grant, CFO on 02 8063 1600
Rebecca Wilson, Media Relations, Buchan Consulting on (03) 9866 4722 / [email protected]
About Nanosonics
Nanosonics Limited is developing a portfolio of decontamination products designed to reduce the spread of infection. The Comp any
ow ns intellectual property relating to a unique disinfection and sterilisation technology w hich can be suited to a variety of markets.
Initial market applications are designed for the reprocessing of reusable medical instruments. The Company’s first product is
designed to disinfect Ultrasound Transducers. In parallel w ith the commercialisation of this product, Nanosonics is also developing
other medical applications and exploring opportunities for its proprietary technology in other industries. For more information about
Nanosonics please visit w ww.nanosonics.com.au